Federal contract award
HT009026FJ075
RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT WITH METASTATIC LESIONS AFTER DEFINITE TREATMENT.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | GPC COMPONENT PROGRAM MANAGER |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36F79719D0170 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $21.7K |
| Current contract value | $21.7K |
| Potential contract value / ceiling | $21.7K |
| Start date | May 28, 2026 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2026 |
| Latest award activity | May 28, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 28, 2026 | 0 | $21.7K | RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT WITH METASTATIC LESIONS AFTER DEFINITE TREATMENT. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.